Finance

Lists
Why is ETON up 13.97%?
Dive Deeper
ETON:NASDAQ
Eton Pharmaceuticals Inc
$64.35
+13.97%
(+7.89) 1D
$64.40
+0.08% (+0.050)
Pre-market
Closed: Nov 9, 4:00:01 PM GMT-5  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for ETON...
Open
$58.10
High
$64.44
Low
$57.02
Mkt. cap
1.84B
Avg. vol.
559.75K
Volume
917.00
P/E ratio
166.82
52-wk high
$66.37
52-wk low
$14.27
EPS
$0.39
Beta
0.89
Shares outstanding
28.84M
No. of employees
44
Open
$58.10
High
$64.44
Low
$57.02
Mkt. cap
1.84B
Avg. vol.
559.75K
Volume
917.00
P/E ratio
166.82
52-wk high
$66.37
52-wk low
$14.27
EPS
$0.39
Beta
0.89
Shares outstanding
28.84M
No. of employees
44
News stories
From web sources and news partners
About Eton Pharmaceuticals Inc
CEO-
Employees44
Founded2017
Headquarters-
SectorHealth Care
IndustryPharmaceutical industry
Analyst ratings
Based on 3 analysts giving stock ratings to ETON in the past 3 months
Strong buy
Buy
3
Hold
0
Sell
0
12-month forecast
Based on 3 Wall Street analysts offering 12 month price targets for ETON in the last 3 months.
Highest
Current $64.35
$82.00 (+27.43%)
Average
$80.67 (+25.36%)
Lowest
$80.00 (+24.32%)
Analyst
Recommendation
Action
Price target
Projected
Date
Chase Knickerbocker
Craig-Hallum
Buy
Maintained
$82.00
+27.4%
11/06/2026
Gary Nachman
Canaccord Genuity
Buy
Reiterated
$80.00
+24.3%
11/06/2026
Swayampakula Ramakanth
H.C. Wainwright
Buy
Maintained
$80.00
+24.3%
11/06/2026
Madison Elsaadi
B. Riley Securities
Buy
Reiterated
$40.00
-37.8%
06/25/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
21.28M
24.27M
37.59M
57.92M
Cost of goods sold
6.76M
9.18M
11.53M
13.15M
Cost of revenue
6.76M
9.18M
11.53M
13.15M
Research and development expenses
1.78M
1.88M
993.00K
5.27M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
8.28M
10.45M
11.63M
16.02M
Operating expense
10.06M
12.32M
12.62M
21.29M
Total operating expenses
16.82M
21.50M
24.14M
34.44M
Operating income
4.47M
2.76M
13.44M
23.48M
Other non operating income
-909.00K
-
-
303.00K
EBT including unusual items
1.41M
1.57M
11.72M
22.36M
EBT excluding unusual items
3.42M
1.92M
12.37M
22.83M
Income tax expense
-69.00K
20.00K
140.00K
-12.89M
Effective tax rate
-4.88%
1.27%
1.19%
-57.66%
Other operating expenses
-
-
-
-
Net income
1.48M
1.55M
11.58M
35.25M
Net profit margin
6.97%
6.40%
30.80%
60.85%
Earnings per share
0.19
0.14
0.43
0.50
Interest and investment income
1.07M
296.00K
-
-
Interest expense
-1.21M
-1.14M
-1.08M
-959.00K
Net interest expenses
-141.00K
-840.00K
-1.08M
-959.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
5.48M
3.90M
14.83M
24.93M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
Google apps